This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adkins, B., Leclerc, C., and Marshall-Clarke, S. (2004). Neonatal adaptive immunity comes of age. Nat. Rev. Immunol., 4, 553–564.
Arreaza, G.A., Cameron, M.J., Jaramillo, A., Gill, B.M., Hardy, D., Laupland, K.B., Rapoport, M.J., Zucker, P., Chakrabarti, S., Chensue, S.W., Qin, H.Y., Singh, B., and Delovitch, T.L. (1997). Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. J. Clin. Invest., 100, 2243–2253.
Atkinson, M.A. and Leiter, E.H. (1999). The NOD mouse model of type 1 diabetes: As good as it gets? Nat. Med., 5, 601–604.
Baxter, A.G., Kinder, S.J., Hammond, K.J., Scollay, R., and Godfrey, D.I. (1997). Association between alphabetaTCR+CD4−CD8− T-cell deficiency and IDDM in NOD/Lt mice. Diabetes, 46, 572–582.
Beaudoin, L., Laloux, V., Novak, J., Lucas, B., and Lehuen, A. (2002). NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity, 17, 725–736.
Benlagha, K., Kyin, T., Beavis, A., Teyton, L., and Bendelac, A. (2002). A thymic precursor to the NKT cell lineage. Science, 296, 553–555.
Benlagha, K., Weiss, A., Beavis, A., Teyton, L., and Bendelac, A. (2000). In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med., 191, 1895–1903.
Berzins, S.P., Kyparissoudis, K., Pellicci, D.G., Hammond, K.J., Sidobre, S., Baxter, A., Smyth, M.J., Kronenberg, M., and Godfrey, D.I. (2004). Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: Implications for human studies. Immunol. Cell Biol., 82, 247–252.
Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A., and Springer, T.A. (1996). A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor-1 (SDF-1). J. Exp. Med., 184, 1101–1109.
Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E., and Brenner, M.B. (2003). Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol., 4, 1230–1237.
Bystry, R.S., Aluvihare, V., Welch, K.A., Kallikourdis, M., and Betz, A.G. (2001). B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol., 2, 1126–1132.
Cameron, M.J., Arreaza, G.A., Grattan, M., Meagher, C., Sharif, S., Burdick, M.D., Strieter, R.M., Cook, D.N., and Delovitch, T.L. (2000). Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type 1 diabetes. J. Immunol., 165, 1102–1110.
Chiba, A., Oki, S., Miyamoto, K., Hashimoto, H., Yamamura, T., and Miyake, S. (2004). Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum., 50, 305–313.
Christianson, S.W., Shultz, L.D., and Leiter, E.H. (1993). Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes, 42, 44–55.
Cruikshank, W.W., Kornfeld, H., and Center, D.M. (2000). Interleukin-16. J. Leukoc. Biol., 67, 757–766.
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., and Taniguchi, M. (1997). Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science, 278, 1623–1626.
Dahlen, E., Dawe, K., Ohlsson, L., and Hedlund, G. (1998). Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J. Immunol., 160, 3585–3593.
Delovitch, T.L. and Singh, B. (1997). The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity, 7, 727–738.
Falcone, M., Facciotti, F., Ghidoli, N., Monti, P., Olivieri, S., Zaccagnino, L., Bonifacio, E., Casorati, G., Sanvito, F., and Sarvetnick, N. (2004). Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol., 172, 5908–5916.
Fuji, N., Ueda, Y., Fujiwara, H., Toh, T., Yoshimura, T., and Yamagishi, H. (2000). Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin-12 in the liver. Clin. Cancer Res., 6, 3380–3387.
Gapin, L., Matsuda, J.L., Surh, C.D., and Kronenberg, M. (2001). NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol., 2, 971–978.
Godfrey, D.I., Hammond, K.J., Poulton, L.D., Smyth, M.J., and Baxter, A.G. (2000). NKT cells: Facts, functions and fallacies. Immunol. Today, 21, 573–583.
Gombert, J.M., Herbelin, A., Tancrede-Bohin, E., Dy, M., Carnaud, C., and Bach, J.F. (1996). Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol., 26, 2989–2998.
Hammond, K.J., Cain, W., van Driel, I., and Godfrey, D. (1998). Three day neonatal thymectomy selectively depletes NK1.1+ T cells. Int. Immunol., 10, 1491–1499.
Hammond, K.J., Pellicci, D.G., Poulton, L.D., Naidenko, O.V., Scalzo, A.A., Baxter, A.G., and Godfrey, D.I. (2001). CD1d-restricted NKT cells: An interstrain comparison. J. Immunol., 167, 1164–1173.
Hong, S., Wilson, M.T., Serizawa, I., Wu, L., Singh, N., Naidenko, O.V., Miura, T., Haba, T., Scherer, D.C., Wei, J., Kronenberg, M., Koezuka, Y., and Van Kaer, L. (2001). The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med., 7, 1052–1056.
Hussain, S., Salojin, K.V., and Delovitch, T.L. (2004). Hyperresponsiveness, resistance to B-cell receptor-dependent activation-induced cell death, and accumulation of hyperactivated B-cells in islets is associated with the onset of insulitis but not type 1 diabetes. Diabetes, 53, 2003–2011.
Kaser, A., Dunzendorfer, S., Offner, F.A., Ludwiczek, O., Enrich, B., Koch, R.O., Cruikshank, W.W., Wiedermann, C.J., and Tilg, H. (2000). B lymphocyte-derived IL-16 attracts dendritic cells and Th cells. J. Immunol., 165, 2474–2480.
Kawano, T., Tanaka, Y., Shimizu, E., Kaneko, Y., Kamata, N., Sato, H., Osada, H., Sekiya, S., Nakayama, T., and Taniguchi, M. (1999). A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. Int. Immunol., 11, 881–887.
Kronenberg, M. and Gapin, L. (2002). The unconventional lifestyle of NKT cells. Nat. Rev. Immunol., 2, 557–568.
Laloux, V., Beaudoin, L., Jeske, D., Carnaud, C., and Lehuen, A. (2001). NKT cell-induced protection against diabetes in Valpha14-Jalpha281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol., 166, 3749–3756.
Laloux, V., Beaudoin, L., Ronet, C., and Lehuen, A. (2002). Phenotypic and functional differences between NKT cells colonizing splanchnic and peripheral lymph nodes. J. Immunol., 168, 3251–3258.
Lee, P.T., Putnam, A., Benlagha, K., Teyton, L., Gottlieb, P.A., and Bendelac, A. (2002). Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest., 110, 793–800.
Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J.F., and Monteiro, R.C. (1998). Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med., 188, 1831–1839.
Lynch, E.A., Heijens, C.A., Horst, N.F., Center, D.M., and Cruikshank, W.W. (2003). Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: Requirement of CCR5. J. Immunol., 171, 4965–4968.
MacDonald, H.R. (2002). Development and selection of NKT cells. Curr. Opin. Immunol., 14, 250–254.
Mashikian, M.V., Ryan, T.C., Seman, A., Brazer, W., Center, D.M., and Cruikshank, W.W. (1999). Reciprocal desensitization of CCR5 and CD4 is mediated by IL-16 and macrophage inflammatory protein-1 beta, respectively. J. Immunol., 163, 3123–3130.
Mathis, D., Vence, L., and Benoist, C. (2001). Beta-cell death during progression to diabetes. Nature, 414, 792–798.
Matin, K., Salam, M.A., Akhter, J., Hanada, N., and Senpuku, H. (2002). Role of stromal cell-derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice, Immunology, 107, 222–232.
Matsuda, J.L., Naidenko, O.V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.R., Koezuka, Y., and Kronenberg, M. (2000). Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med., 192, 741–754.
Mi, Q.S., Ly, D., Zucker, P., McGarry, M., and Delovitch, T.L. (2004). Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells. Diabetes, 53, 1303–1310.
Mi, Q.S., Meagher, C., and Delovitch, T.L. (2003). CD1d-restricted NKT regulatory cells: Functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes. Novartis Found. Symp., 252, 146–160.
Miyamoto, K., Miyake, S., and Yamamura, T. (2001). A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature, 413, 531–534.
Naumov, Y.N., Bahjat, K.S., Gausling, R., Abraham, R., Exley, M.A., Koezuka, Y., Balk, S.B., Strominger, J.L., Clare-Salzer, M., and Wilson, S.B. (2001). Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA, 98, 13838–13843.
Oikawa, Y., Shimada, A., Yamada, S., Motohashi, Y., Nakagawa, Y., Irie, J., Maruyama, T., and Saruta, T. (2002). High frequency of Valpha24(+) Vbeta11(+) T-cells observed in type 1 diabetes. Diabetes Care, 25, 1818–1823.
Oikawa, Y., Shimada, A., Yamada, S., Motohashi, Y., Nakagawa, Y., Irie, J., Maruyama, T., and Saruta, T. (2003). NKT cell frequency in Japanese type 1 diabetes. Ann. NY Acad. Sci., 1005, 230–232.
Oki, S., Chiba, A., Yamamura, T., and Miyake, S. (2004). The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest., 113, 1631–1640.
Ortaldo, J.R., Young, H.A., Winkler-Pickett, R.T., Bere, E.W., Jr., Murphy, W.J., and Wiltrout, R.H. (2004). Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J. Immunol., 172, 943–953.
Pankewycz, O., Strom, T.B., and Rubin-Kelley, V.E. (1991). Islet-infiltrating T cell clones from nonobese diabetic mice that promote or prevent accelerated onset of diabetes. Eur. J. Immunol., 21, 873–879.
Pellicci, D.G., Hammond, K.J., Uldrich, A.P., Baxter, A.G., Smyth, M.J., and Godfrey, D.I. (2002). A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(−) CD4(+) CD1d-dependent precursor stage. J. Exp. Med., 195, 835–844.
Poulton, L.D., Smyth, M.J., Hawke, C.G., Silveira, P., Shepherd, D., Naidenko, O.V., Godfrey, D.I., and Baxter, A.G. (2001). Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol., 13, 887–896.
Pulendran, B., Lingappa, J., Kennedy, M.K., Smith, J., Teepe, M., Rudensky, A., Maliszewski, C.R., and Maraskovsky, E. (1997). Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol., 159, 2222–2231.
Salomon, B., Lenschow, D.J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., and Bluestone, J.A. (2000). B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity, 12, 431–440.
Serreze, D.V., Leiter, E.H., Christianson, G.J., Greiner, D., and Roopenian, D.C. (1994). Major histocompatibility complex class 1-deficient NOD-B2m null mice are diabetes and insulitis resistant. Diabetes, 43, 505–509.
Sharif, S., Arreaza, G.A., Zucker, P., Mi, Q.S., and Delovitch, T.L. (2002). Regulation of autoimmune disease by natural killer T cells. J. Mol. Med., 80,290–300.
Sharif, S., Arreaza, G.A., Zucker, P., Mi, Q.S., Sondhi, J., Naidenko, O.V., Kronenberg, M., Koezuka, Y., Delovitch, T.L., Gombert, J.M., Leite-De-Moraes, M., Gouarin, C., Zhu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., Lehuen, A., Bach, J.F., and Herbelin, A. (2001). Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med., 7, 1057–1062.
Sonoda, K.H., Faunce, D.E., Taniguchi, M., Exley, M., Balk, S., and Stein-Streilein, J. (2001). NKT cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol., 166, 42–50.
Sonoda, K.H. and Stein-Streilein, J. (2002). CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J. Immunol., 32, 848–857.
Taniguchi, M., Harada, M., Kojo, S., Nakayama, T., and Wakao, H. (2003). The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol., 21, 483–513.
Thomas-Vaslin, V., Damotte, D., Coltey, M., Le Douarin, N.M., Coutinho, A., and Salaun, J. (1997). Abnormal T cell selection on NOD thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice. Proc. Natl. Acad. Sci. USA, 94, 4598–4603
Tisch, R. and McDevitt, H. (1996). Insulin-dependent diabetes mellitus. Cell, 85, 291–297.
Toura, I., Kawano, T., Akutsu, Y., Nakayama, T., Ochiai, T., and Taniguchi, M. (1999). Cutting edge: Inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J. Immunol., 163, 2387–2391.
Wang, B., Geng, Y.B., and Wang, C.R. (2001). CD1-restricted NKT cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med., 194, 313–320.
Wicker, L.S., Leiter, E.H., Todd, J.A., Renjilian, R.J., Peterson, E., Fischer, P.A., Podolin, P.L., Zijlstra, M., Jaenisch, R., and Peterson, L.B. (1994). Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes, 43, 500–504.
Wilson, S.B. and Delovitch, T.L. (2003). Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol., 3, 211–222.
Wilson, S.B., Kent, S.C., Patton, K.T., Orban, T., Jackson, R.A., Exley, M., Porcelli, S., Schatz, D.A., Atkinson, M.A., Balk, S.P., Strominger, J.L., and Hafler, D.A. (1998). Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature, 391, 177–181.
Wu, A.J., Hua, H., Munson, S.H., and McDevitt, H.O. (2002). Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA, 99, 12287–12292.
Yamamura, T., Miyamoto, K., Illes, Z., Pal, E., Araki, M., and Miyake, S. (2004). NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease. Curr. Top. Med. Chem., 4, 561–567.
Yang, Y., Bao, M., and Yoon, J.W. (2001). Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse. Diabetes, 50, 2691–2699.
Zlotnik, A. and Yoshie, O. (2000). Chemokines: A new classification system and their role in immunity. Immunity, 12, 121–127.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Hussain, S., Ly, D., Wagner, M., Delovitch, T.L. (2005). NKT Cells and Autoimmune Type 1 Diabetes. In: Zouali, M. (eds) Molecular Autoimmunity. Springer, Boston, MA. https://doi.org/10.1007/0-387-24534-0_4
Download citation
DOI: https://doi.org/10.1007/0-387-24534-0_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24533-1
Online ISBN: 978-0-387-24534-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)